Inmune Bio clinical trials we track

Check company identity source

Phase 2 / 3 1 trial

TrialDrugs studiedStatusPrimary completion
INB03 for the Treatment of Pulmonary Complications From COVID-19NCT04370236INB03Terminated2021-10-13Actual

Phase 2 2 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Proportion of Participants With Disease Progression From Randomization to 28 Days Post-randomization. After: Measure: Cochran-Mantel-Haenszel Analysis of Proportion of Patients With Disease Progression.

Check registry source